Skip to main content
Caplight Logo









Fluoro2 Therapeutics

Fluoro2 Therapeutics

Private
Boca Raton, FloridaHealthcare & Life Scienceshttps://fluoro2.com

Company Overview

Fluoro2 Therapeutics is a biotechnology company developing a perfluorocarbon nanoemulsion designed as an artificial blood substitute for use in trauma, hemorrhage, and other medical situations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

blood substituteartificial bloodperfluorocarbonoxygen carriernanoemulsionbiotechnologymedical devicetrauma caretransfusion medicineGMP manufacturingsynthetic therapeuticsblood shortage solution

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fluoro2 Therapeutics Comparables

Compare Fluoro2 Therapeutics with similar companies based on industry and business-model similarity.

Fluoro2 Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KaloCyte, Inc.
84%
VirTech Bio
84%
HbO2 Therapeutics
84%

Fluoro2 Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Fluoro2 Therapeutics Filings

Explore SEC and related filing metadata, where available.

Fluoro2 Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fluoro2 Therapeutics's valuation, stock price, and market status.

Is Fluoro2 Therapeutics a public or private company?

Fluoro2 Therapeutics is a private company.

What is the current stock price of Fluoro2 Therapeutics?

Fluoro2 Therapeutics is a private company with no public stock price. Caplight tracks Fluoro2 Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Fluoro2 Therapeutics worth (valuation)?

Valuation information for Fluoro2 Therapeutics is not publicly available.

Can I buy Fluoro2 Therapeutics stock?

Fluoro2 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Fluoro2 Therapeutics's last funding round?

Funding round information for Fluoro2 Therapeutics is not publicly available.

Who are the main investors in Fluoro2 Therapeutics?

Investor information for Fluoro2 Therapeutics is not publicly disclosed.

Will Fluoro2 Therapeutics IPO soon?

No public IPO plans have been announced for Fluoro2 Therapeutics.

How can I track Fluoro2 Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fluoro2 Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoca Raton, Florida
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?